Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses

This publication has 16 references indexed in Scilit:

• Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen
  Journal of Controlled Release, 2010
• Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
  Journal of Liposome Research, 2009
• The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes
  Immunology, 2007
• Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen
  Journal of Controlled Release, 2007
• Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2005
• Liposomes as sustained release system for human interferon-γ: biopharmaceutical aspects
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2001
• Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to Mice
  Journal of Pharmaceutical Sciences, 1994
• Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes
  Nature Biotechnology, 1984
• Liposomes as immunological adjuvants
  Nature, 1974
• Diffusion of univalent ions across the lamellae of swollen phospholipids
  Journal of Molecular Biology, 1965